10.08.18
FAREVA has selected TraceLink's serialization solutions for compliance with the EU Falsified Medicines Directive (FMD). TraceLink and FAREVA will be at CPhI Worldwide, partnering together to provide education around EU FMD readiness and serialization.
FAREVA is a global pharmaceutical and API CDMO that provides various dosage forms and API, as well as packing services. The company operates 35 sites across Europe, Russia, Turkey and The Americas. The company needed a serialization solution to ensure compliance ahead of the February 2019 deadline, as well as enable successful data exchange.
"Serialization impacts every aspect of the pharmaceutical supply chain, and as a CDMO, we recognize the critical role we play in regard to industry preparedness. After a thorough evaluation, TraceLink stood out as the only provider who had a solution that would eliminate the time-intensive and cost prohibitive task of point-to-point connections, while also allowing us to streamline data exchange with our customers and support them in being compliant with serialization regulations," said Sebastien Poncet, vice president of sales at FAREVA.
FAREVA is a global pharmaceutical and API CDMO that provides various dosage forms and API, as well as packing services. The company operates 35 sites across Europe, Russia, Turkey and The Americas. The company needed a serialization solution to ensure compliance ahead of the February 2019 deadline, as well as enable successful data exchange.
"Serialization impacts every aspect of the pharmaceutical supply chain, and as a CDMO, we recognize the critical role we play in regard to industry preparedness. After a thorough evaluation, TraceLink stood out as the only provider who had a solution that would eliminate the time-intensive and cost prohibitive task of point-to-point connections, while also allowing us to streamline data exchange with our customers and support them in being compliant with serialization regulations," said Sebastien Poncet, vice president of sales at FAREVA.
